The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
Open accessAbstract
A clue to a drug's neurotoxicity?: The drug BIA 10-2474 inhibits fatty acid amide hydrolase (FAAH), a lipase that degrades a specific endocannabinoid. On the basis of this activity, BIA 10-2474 was being developed as a potential treatment for anxiety and pain. In a phase 1 trial of the drug, one subject died, and four others suffered brain damage. As an initial step in investigating whether inhibition of off-target proteins by BIA 10-2474 might contribute to its clinical neurotoxicity, van Esbroeck et al. used activity-based proteomic assays to identify proteins targeted by the drug. Studying human cells and brain samples from subjects not associated with the trial, they found that BIA 10-2474 targeted several different lipases in addition to FAAH. It also substantially altered lipid metabolism in cultured neurons. Science , this issue p. 1084
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During the period of its suspension, it was revealed that these problems were due to off-target effects of this agent that led to alterations in lipid networks in the cortexeffects which were not observed in more specific FAAH inhibitors (van Esbroeck et al., 2017).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as van Esbroeck et al., 2017
In the citing paper
“In light of the death and adverse events in other subjects given repeated high doses of the FAAH inhibitor BIA-102474-101 in a clinical trial (Kerbrat et al, 2016), it is crucial to note that this drug has multitude of off-targets, including inhibition of essential blood-clotting factors thrombin and Factor VII (van Esbroeck et al, 2017;Molinski et al, 2017), which may contributed to its toxicity.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as van Esbroeck et al, 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,143
Self-citationLong, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim‐Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 405
Self-citationHuggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375
Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 374
Self-citationA road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Lanning, B. R., Whitby, L. R., Dix, M. M., Douhan, J., Gilbert, A. M., Hett, E. C., Johnson, T., Joslyn, C. M., Kath, J. C., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1582 · Cited by 356
Self-citationBachovchin, D. A., Ji, T., Li, W., Simon, G. M., Blankman, J. L., Adibekian, A., Hoover, H. S., Niessen, S., & Cravatt, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011663107 · Cited by 274
Self-citationAnandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., PETROCELLIS, L. D., Moriello, A. S., Campi, B., McNaughton, P. A., Geppetti, P., & Marzo, V. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 243
Ahn, K., Smith, S. E., Liimatta, M. B., Beidler, D. R., Sadagopan, N., Dudley, D. T., Young, T., Wren, P. B., Zhang, Y., Swaney, S. M., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180257 · Cited by 232
Self-citationDual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission
Hampson, A. J., Bornheim, L. M., Scanziani, M., Yost, C. S., Gray, A. T., Hansen, B. M., Leonoudakis, D., & Bickler, P. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020671.x · Cited by 214
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Johnson, D. S., Stiff, C. M., Lazerwith, S. E., Kesten, S. R., Fay, L. K., Morris, M. J., Beidler, D. R., Liimatta, M. B., Smith, S. E., Dudley, D. T., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100190t · Cited by 200
Self-citationHu, C., van Dommelen, J., van der Heijden, R., Spijksma, G. K., Reijmers, T. H., Wang, M., Slee, E. A., Lü, X., Xu, G., van der Greef, J., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800373m · Cited by 174
Self-citationThe hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase
Inloes, J. M., Hsu, K., Dix, M. M., Viader, A., Masuda, K. R., Takei, T., Wood, M. R., & Cravatt, B. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413706111 · Cited by 172
Self-citationAcute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
Kerbrat, A., Ferré, J.-C., Fillatre, P., Ronzière, T., Vannier, S., Carsin-Nicol, B., Lavoué, S., Vérin, M., Gauvrit, J.-Y., Le Tulzo, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604221 · Cited by 171
Ogasawara, D., Deng, H., Viader, A., Baggelaar, M. P., Breman, A. C., den Dulk, H., van den Nieuwendijk, A. M. C. H., Soethoudt, M., van der Wel, T., Zhou, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522364112 · Cited by 158
Self-citationThe Serine Hydrolase ABHD6 Is a Critical Regulator of the Metabolic Syndrome
Thomas, G., Betters, J. L., Lord, C. C., Brown, A. L., Marshall, S., Ferguson, D., Sawyer, J. K., Davis, M. A., Melchior, J., Blume, L. C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.047 · Cited by 129
Self-citationLi, G. L., Winter, H. R., Arends, R., Jay, G. W., Le, V., Young, T., & Huggins, J. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04137.x · Cited by 127
Neuropathy target esterase impairments cause Oliver–McFarlane and Laurence–Moon syndromes
Hufnagel, R. B., Arno, G., Hein, N. D., Hersheson, J., Prasad, M. K., Anderson, Y. C., Krueger, L. A., Gregory, L. C., Stoetzel, C., Jaworek, T. J., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102856 · Cited by 123
Neuropathy target esterase (NTE): overview and future
Richardson, R. J., Hein, N. D., Wijeyesakere, S. J., Fink, J. K., & Махаева, Г. Ф. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.10.024 · Cited by 115
Topaloglu, A. K., Lomniczi, A., Kretzschmar, D., Dissen, G. A., Kotan, L. D., McArdle, C. A., Koç, A., Hamel, B. C. J., Güçlü, M., Çakır, E. D. P., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1836 · Cited by 103
Neuropathy Target Esterase Is Required for Adult Vertebrate Axon Maintenance
Read, D. J., Li, Y., Chao, M. V., Cavanagh, J. B., & Glynn, P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-09.2009 · Cited by 99
Mukhopadhyay, P., Baggelaar, M. P., Erdélyi, K., Cao, Z., Çınar, R., Fezza, F., Ignatowska-Jankowska, B. M., Wilkerson, J. L., van Gils, N., Hansen, T. R., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13338 · Cited by 86
Self-citationBaggelaar, M. P., Janssen, F. J., van Esbroeck, A. C. M., den Dulk, H., Allarà, M., Hoogendoorn, S., McGuire, R., Florea, B. I., Meeuwenoord, N. J., van den Elst, H., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306295 · Cited by 79
Self-citationScientists in the dark after French clinical trial proves fatal
Butler, D., & Callaway, E. (2016) · Nature · doi:10.1038/nature.2016.19189 · Cited by 77
Bertrand, D., Bertrand, S., Neveu, E., & FERNANDES, P. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-10 · Cited by 74
Baggelaar, M. P., Chameau, P. J. P., Kantae, V., Hummel, J. J. A., Hsu, K., Janssen, F. J., van der Wel, T., Soethoudt, M., Deng, H., den Dulk, H., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04883 · Cited by 67
Self-citationImplications of the BIA‐102474‐101 study for review of first‐into‐human clinical trials
Eddleston, M., Cohen, A. F., & Webb, D. J. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12920 · Cited by 66
Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases
Cognetta, A. B., Niphakis, M. J., Lee, H., Martini, M. L., Hulce, J. J., & Cravatt, B. F. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.018 · Cited by 64
Self-citationCloning and expression of the murine sws/NTE gene
Moser, M., Stempfl, T., Li, Y., Glynn, P., Büttner, R., & Kretzschmar, D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00239-7 · Cited by 61
Gattinoni, S., Simone, C. D., Dallavalle, S., Fezza, F., Nannei, R., Amadio, D., Minetti, P., Quattrociocchi, G., Caprioli, A., Borsini, F., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.200900472 · Cited by 44
Self-citationRoumen, L., Peeters, J. W., Emmen, J. M. A., Beugels, I. P. E., Custers, E. M. G., de Gooyer, M. E., Plate, R., Pieterse, K., Hilbers, P. A. J., Smits, J. F. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901356d · Cited by 41
Ligresti, A., Martos, J. L., Wang, J. W., Guida, F., Allarà, M., Palmieri, V., Luongo, L., Woodward, D. F., & Marzo, V. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12410 · Cited by 35
Self-citationNeuropathy target esterase: An essential enzyme for neural development and axonal maintenance
Chang, P., & Wu, Y. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.007 · Cited by 35
Janssen, F. J., Deng, H., Baggelaar, M. P., Allarà, M., van der Wel, T., den Dulk, H., Ligresti, A., van Esbroeck, A. C. M., McGuire, R., Marzo, V. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500681z · Cited by 34
Self-citationFast Halogenation of Some N‐Heterocycles by Means of N,N′‐Dihalo‐5,5‐dimethylhydantoin
Sandtorv, A. H., & Bjørsvik, H. (2013) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201200723 · Cited by 31
A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α
van der Wel, T., Janssen, F. J., Baggelaar, M. P., Deng, H., den Dulk, H., Overkleeft, H. S., & van der Stelt, M. (2015) · Journal of Lipid Research · doi:10.1194/jlr.d056390 · Cited by 30
Self-citationRostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- A. Patat presentation at the Safety and Regulation in Early Clinical Drug Development Symposium Ghent Belgium 2 December 2016.
Cited by
Sorted by citations
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,448
Scinto, S. L., Bilodeau, D. A., Hincapie, R., Lee, W., Nguyen, S. S., Xu, M., Ende, C. W. A., Finn, M. G., Lang, K., Lin, Q., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00028-z · Cited by 654
New approaches and challenges to targeting the endocannabinoid system
Marzo, V. D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 502
Pound, P., & Ritskes-Hoitinga, M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1678-1 · Cited by 419
Click Chemistry in Proteomic Investigations
Parker, C. G., & Pratt, M. R. (2020) · Cell · doi:10.1016/j.cell.2020.01.025 · Cited by 391
Metadata
- Authors
- van Esbroeck, A. C. M., Janssen, A. P. A., Cognetta, A. B., Ogasawara, D., Shpak, G., van der Kroeg, M., Kantae, V., Baggelaar, M. P., de Vrij, F. M. S., Deng, H., Allarà, M., Fezza, F., Lin, Z., van der Wel, T., Soethoudt, M., Mock, E. D., den Dulk, H., Baak, I. L., Florea, B. I., Hendriks, G., De Petrocellis, L., Overkleeft, H. S., Hankemeier, T., De Zeeuw, C. I., Di Marzo, V., Maccarrone, M., Cravatt, B. F., Kushner, S. A., & van der Stelt, M.
- Affiliations
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, Netherlands.
- Leiden University (NL)
- Scripps Research Institute (US)
- Erasmus MC (NL)
- Department of Psychiatry, Erasmus University Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Istituto di Chimica Biomolecolare (IT)
- University of Rome Tor Vergata (IT)
- Toxys B.V., Robert Boyleweg 4, 2333 CG, Leiden, Netherlands.
- Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche (CNR), Via Campi Flegrei 34, Comprensorio Olivetti, 80078 Pozzuoli, Italy.
- Department of Neuroscience, Erasmus Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Università Campus Bio-Medico (IT)
- Corresponding author
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Kushner, Steven A.
- ORCID
- van Esbroeck, Annelot C. M.
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Shpak, Guy
- van der Kroeg, Mark
- Kantae, Vasudev
- Baggelaar, Marc P.
- Deng, Hui
- Allarà, Marco
- Fezza, Filomena
- Lin, Zhanmin
- van der Wel, Tom
- Soethoudt, Marjolein
- Mock, Elliot D.
- den Dulk, Hans
- Baak, Ilse L.
- Florea, Bogdan I.
- Hendriks, Giel
- De Petrocellis, Luciano
- Overkleeft, Herman S.
- Hankemeier, Thomas
- Di Marzo, Vincenzo
- Maccarrone, Mauro
- Cravatt, Benjamin F.
- Kushner, Steven A.
- van der Stelt, Mario
- Venue
- Science
- Published
- 2017-06-09
- Volume
- 356
- Issue
- 6342
- Pages
- 1084-1087
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5641481
- OpenAlex
- W2621737540
- Cited by
- 332
- References
- 40
- Citations by year
- 2026: 23 · 2025: 20 · 2024: 33 · 2023: 25 · 2022: 27 · 2021: 33 · 2020: 63 · 2019: 50 · 2018: 47 · 2017: 10
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Leiden Repository (Leiden University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Funders
- National Institutes of Health (award304469, DA033760)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- FAAH inhibitors, off-target effects, lipase inhibition, neurotoxicity, activity-based protein profiling, fatty acid amide hydrolase, lipid metabolism, cortical neurons, drug safety
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Analgesics, Cross Reactions, Cyclic N-Oxides, Humans, Neurons, Pyridazines, Pyridines, Anti-Anxiety Agents, Urea, Clinical Trials, Phase I as Topic, Cell Line, Tumor, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
